Glycoconjugate Journal

, Volume 10, Issue 1, pp 120–126 | Cite as

Different binding capacities of influenza A and Sendai viruses to gangliosides from human granulocytes

  • Johannes Müthing
  • Frank Unland
  • Dagmar Heitmann
  • Michaela Orlich
  • Franz-Georg Hanisch
  • Jasna Peter-Katalinić
  • Vera Knäuper
  • Harald Tschesche
  • Sørge Kelm
  • Roland Schauer
  • Jürgen Lehmann


The structures of gangliosides from human granulocytes were elucidated by fast atom bombardment mass spectrometry and by gas chromatography/mass spectrometry as their partially methylated alditol acetates. In human granulocytes besides GM3 (II3Neu5Ac-LacCer), neolacto-series gangliosides (IV3Neu5Ac-nLcOse4Cer, IV6Neu5Ac-nLcOse4Cer and VI3Neu5Ac-nLcOse6Cer) containing C24:1, and to some extent C22:0; and C16:0 fatty acid in their respective ceramide portions, were identified as major components. In this study we demonstrate that gangliosides from human granulocytes, the second most abundant cells in peripheral blood, can serve as receptors for influenza viruses A/PR/8/34 (H1N1), A/X-31 (H3N2), and a parainfluenza virus Sendai virus (HNF1, Z-strain). Viruses were found to exhibit specific adhesion to terminal Neu5Acα2-3Gal and/or Neu5Acα2-6Gal sequences as well as depending on the chain length of ganglioside carbohydrate backbones from human granulocytes, these important effector cells which represent the first line of defence in immunologically mediated reactions.


Gangliosides human granulocytes TLC overlay assay receptor influenza A virus Sendai virus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schauer R (1988)Adv Exp Med Biol 228:47–72.Google Scholar
  2. 2.
    Kiguchi K, Henning-Chubb CB, Hubermann E (1990)J Biochem (Tokyo)107:8–14.Google Scholar
  3. 3.
    Fukuda MN, Dell A, Oates JE, Wu P, Klock JC, Fukuda M (1985)J Biol Chem 260:1067–82.Google Scholar
  4. 4.
    Paulson JC (1985) InThe Receptors, Vol. II (Conn PM, ed) pp. 131–219. Orlando: Academic Press.Google Scholar
  5. 5.
    Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, Nakajima K (1991)Virology 182:475–85.Google Scholar
  6. 6.
    Markwell MAK, Svennerholm L, Paulson JC (1981)Proc Natl Acad Sci USA 78:5406–10.Google Scholar
  7. 7.
    Markwell MAK, Moss J, Hom BE, Fishman PH, Svennerholm L (1986)Virology 155:356–64.Google Scholar
  8. 8.
    Hansson GC, Karlsson KA, Larson G, Strömberg N, Thurin J, Örvell C, Norrby E (1984)FEBS Lett 170:15–8.Google Scholar
  9. 9.
    Umeda M, Nojima S, Inoue K (1984)Virology 133:172–82.Google Scholar
  10. 10.
    Suzuki Y, Nagao Y, Kato H, Matsumoto M, Nerome K, Nakajima K, Nobusawa E (1986)J Biol Chem. 261:17057–61.Google Scholar
  11. 11.
    Karlsson KA, Strömberg N (1987)Methods Enzymol 138:220–32.Google Scholar
  12. 12.
    Engelbrecht S, Pieper E, Macartney H, Rautenberg W, Wenzel HR, Tschesche H (1982)Hoppe Seyler's Z Physiol Chem 363:305–15.Google Scholar
  13. 13.
    Ledeen RW, Yu RK (1982)Methods Enzymol 83:138–91.Google Scholar
  14. 14.
    Müthing J, Peter-Katalinic J, Hanisch FG, Neumann U (1991)Glycoconjugate J 8:414–23.Google Scholar
  15. 15.
    Folch J, Lees M, Sloane Stanley GH (1957)J Biol Chem 226:497–509.Google Scholar
  16. 16.
    Müthing J, Egge H, Kniep B, Mühlradt PF (1987)Eur J Biochem 163:407–16.Google Scholar
  17. 17.
    Ueno K, Ando S, Yu RK (1978)J Lipid Res 19:863–71.Google Scholar
  18. 18.
    Svennerholm L (1957)Biochim Biophys Acta 24:604–11.Google Scholar
  19. 19.
    Müthing J, Unland F (1992)Biomed Chromatogr 6:227–30.Google Scholar
  20. 20.
    Magnani JL, Smith DF, Ginsburg V (1980)Anal Biochem 109:399–402.Google Scholar
  21. 21.
    Wu G, Ledeen R (1988)Anal Biochem 173:368–75.Google Scholar
  22. 22.
    Peter-Katalinić J, Egge H (1990)Methods Enzymol 193:713–33.Google Scholar
  23. 23.
    Levery SB, Hakomori SI (1987)Methods Enzymol 138:13–25.Google Scholar
  24. 24.
    Hanisch FG, Peter-Katalinić J (1992)Eur J Biochem 205:527–35.Google Scholar
  25. 25.
    Orlich M, Khatchikian D, Teigler A, Rott R (1990)Virology 176:531–38.Google Scholar
  26. 26.
    Reuter G, Schauer R (1988)Glycoconjugate J 5:133–35.Google Scholar

Copyright information

© Chapman & Hall 1993

Authors and Affiliations

  • Johannes Müthing
    • 1
  • Frank Unland
    • 1
  • Dagmar Heitmann
    • 1
  • Michaela Orlich
    • 2
  • Franz-Georg Hanisch
    • 3
  • Jasna Peter-Katalinić
    • 4
  • Vera Knäuper
    • 5
  • Harald Tschesche
    • 5
  • Sørge Kelm
    • 6
  • Roland Schauer
    • 6
  • Jürgen Lehmann
    • 1
  1. 1.Institut für ZellkulturtechnikUniversität BielefeldBielefeldGermany
  2. 2.Institut für VirologieJustus-Liebig-Universität GießenGießenGermany
  3. 3.Institut für ImmunbiologieUniversität KölnKöln 15Germany
  4. 4.Institut für Physiologische ChemieUniversität BonnBonnGermany
  5. 5.Institut für BiochemieUniversität BielefeldBielefeldGermany
  6. 6.Institut für BiochemieChristian-Albrechts Universität KielKielGermany

Personalised recommendations